Tyagarajan N. V.'s Form 4 filing
Genpact LTD (G) · filed Oct 5, 2022
- Accession no.
- 0001567619-22-018281
- Filed
- Oct 5, 2022
- Trade date
- Oct 3-5, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $6.80M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tyagarajan N. V.CIK 0001408239 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2022 | Common Shares | MOption exerciseAcquired | +50,000 | $19.35 | +$967,500 | 694,377 | Direct | |
| Oct 3, 2022 | Common Shares | SSaleDisposed | −49,700 | $44.47F1 | −$2,210,159 | 644,677 | Direct | |
| Oct 3, 2022 | Common Shares | SSaleDisposed | −300 | $43.75 | −$13,125 | 644,377 | Direct | |
| Oct 4, 2022 | Common Shares | MOption exerciseAcquired | +50,000 | $19.35 | +$967,500 | 694,377 | Direct | |
| Oct 4, 2022 | Common Shares | SSaleDisposed | −50,000 | $45.66F2 | −$2,283,000 | 644,377 | Direct | |
| Oct 5, 2022 | Common Shares | MOption exerciseAcquired | +50,000 | $19.35 | +$967,500 | 694,377 | Direct | |
| Oct 5, 2022 | Common Shares | SSaleDisposed | −50,000 | $45.81F3 | −$2,290,500 | 644,377 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2022 | Common Shares | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 1,450,000 | Direct | |
| Oct 4, 2022 | Common Shares | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 1,400,000 | Direct | |
| Oct 5, 2022 | Common Shares | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 1,350,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.91 to $44.84. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F2
The price in Column 4 is a weighted average price. The actual sales price for these transactions ranged from $45.00 to $45.93. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
The price in Column 4 is a weighted average price. The actual sales price for these transactions ranged from $45.46 to $46.12. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
Remarks
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.